Pharmazz, Inc. is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target critical care medicine. The company is developing several clinical-stage product candidates, PMZ-2010, PMZ-1620 and PMZ-2123 for which it holds global marketing rights.
Established in 2010, Pharmazz Inc. is an emerging global pharmaceutical company. Focus of the company is to discover, acquire, develop and market novel pharmaceutical products for use in critical care and hospital settings.
In developing a formulation it is vital that scientists take into consideration how and where the finished product is to be used.
At Pharmazz, Inc. we pride ourselves on our ability to create innovative and exacting solutions that are tailored to customer’s ever evolving requirements.
Pharmazz, Inc. is capable of providing services in Clinical Research, Regulatory Consulting, Data Management, Quality Management and Auditing, and more.